Actually I am absolutely shocked that AHZ has not been a takeover target by big pharma, with a Market Cap of $A 150m M and the AUD/USD exchange rate effectively making the MC $A120m it is the buy of the century, an absolute no-brainer. Just think about it you only need CC NPAT of $A10m at a PE of 15 plus you get a free vax business with a potential $B+. Absolutely crazy and management haven't been able to get any overseas investors to jump on board or put a deal together and sell out. IMO the jury is still out on this management and the next six months will determine their fate going forward.
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-68
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |